Short, Standardized 'Manogram' biparametric MRIs: PRISM’s Bid to Avoid a New PSA‑Era Free‑for‑All, Prevent Another PSA-Style Mess, by @journotwitopen.substack.com/pub/howard…
Breaking: UK expert panel says 'no' to routine PSA screening. Issue moves on to health ministries for final decisions., by @journotwitopen.substack.com/pub/howard…
'A Plea To All Doctors (from a doctor with cancer): Five lessons on bedside manner I would love my colleagues to learn,' Dr. Hannah Harris, by @journotwitopen.substack.com/pub/howard…
Part 2. Low T, low-risk prostate cancer. Safe to treat with testosterone. But new indications low T poses risk for cancer progression open.substack.com/pub/howard…
Part 2. Low T, low-risk prostate cancer. Safe to treat with testosterone. But new indications low T poses risk for cancer progression open.substack.com/pub/howard…
Do an estimated 2k American deaths/year from prostate biopsy stand up against new study showing zero deaths in a 30-year study of prostate biopsy malpractice suits?, by @journotwitopen.substack.com/pub/howard…
Special sports edition. Shrouds of AS Silence: Star athletes open about PCa treatment, but secretive about Active Surveillance? , by @journotwitopen.substack.com/pub/howard…